Canopy Growth is Reporting Q2 Fiscal 2023 Earnings Results Soon
International cannabis conglomerate Canopy Growth Corp. (TSX: WEED) (NASDAQ: CGC) is expected to release its financials for the second quarter of fiscal year 2023 that ended September 30, 2022 before North American financial markets open on Wednesday, November 9th, 2022.
Following the market open and the release of its Q2 2023 earnings results, Canopy Growth Corp. will host an audio webcast with David Klein, the company’s CEO and Judy Hong, the company’s CFO, on November 9th, 2022, at 10:00 AM Eastern Time.
Canopy shareholders can submit questions starting on Wednesday, November 2nd, 2022, at 10:00 AM ET exactly one week prior to the start of the audio webcast by visiting this link. The question submission platform will close on November 8, 2022, at 10:00 AM ET.
For those investors and traders looking to tune in live to Canopy Growth’s Q2 fiscal 2023 audio webcast, it will be available at this link.
For those who can’t tune into the webcast live, Canopy Growth will make a replay accessible until 11:59 PM ET on February 8th, 2023 at this link.
About Canopy Growth Corporation
Canopy Growth Corp. is a world-leading diversified cannabis and cannabinoid-based consumer product company, offering product varieties in high-quality dried flower, oil, softgel capsule, infused beverage, edible, and topical formats, as well as vaporizer devices. Canopy’s global medical marijuana brand, Spectrum Therapeutics, sells a range of full-spectrum products using its colour-coded classification system and is a market leader in both Canada and Germany. Through Canopy’s award-winning Tweed and Tokyo Smoke banners, they reach adult-use consumers and have built a loyal following by focusing on top quality products and meaningful customer relationships. Canopy Growth has entered into the health and wellness consumer space in key markets including Canada, the United States, and Europe through BioSteel sports nutrition, and This Works skin and sleep solutions; and has introduced additional hemp derived CBD products to the United States through their First & Free and Martha Stewart CBD brands. Additionally, Canopy Growth has an established partnership with Fortune 500 alcohol leader Constellation Brands Inc. (NYSE: STZ).
Anyone daring enough to place their bullish/bearish bets in the comments here?